Relay Therapeutics Relay Therapeutics (NASDAQ: RLAY) Announces Acquisition of ZebiAI Relay Therapeutics, Inc. (NASDAQ: RLAY) disclosed Friday that it has acquired ZebiAI. Both the firms will join hands to speed up the use of ML across the Dynamo platform.
